Study Stopped
principle investigator moved to an another hospital
The Effect of Surfactant Administration on Cerebral Oxygenation
The Effect of the Type and the Method of Surfactant Administration on Oxygenation in Preterm Infants: a Near Infrared Spectroscopy Study
1 other identifier
observational
40
1 country
1
Brief Summary
The purpose of this study is to assess changes in cerebral oxygenation during two different types (beractant and poractant) and two different routes (double lumen or single lumen endotracheal tube) of surfactant administration using near infrared spectroscopy (NIRS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2010
CompletedFirst Submitted
Initial submission to the registry
December 7, 2010
CompletedFirst Posted
Study publicly available on registry
December 13, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedSeptember 5, 2016
November 1, 2010
7.6 years
December 7, 2010
September 1, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
to determine the optimal and the most safe surfactant administration technique with regard to cerebral oxygenation as measured by near infrared spectroscopy in low birth weigh infants
up to 36 weeks
Study Arms (1)
group 1, group 2, group 3, group 4
administration of beractant with single lumen ET tube administration of poractant with single lumen ET tube administration of beractant with double lumen ET tube administration of poractant with double lumen ET tube
Interventions
monitorization of cerebral oxygenation by INVOS 5100 during surfactant administration
Eligibility Criteria
\<32 week or \<1500 g required surfactant treatment for established RDS
You may qualify if:
- Clinical diagnosis of respiratory distress syndrome \<32 gestational weeks and/or \<1500 g birthweight
You may not qualify if:
- major congenital anomalies complex congenital heart diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zekai Tahir Burak Maternity Teaching Hospital, Neonatal Intensive Care Unit
Ankara, 06100, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 7, 2010
First Posted
December 13, 2010
Study Start
November 1, 2010
Primary Completion
June 1, 2018
Study Completion
December 1, 2018
Last Updated
September 5, 2016
Record last verified: 2010-11